未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Basal Cell Carcinoma 2025日本皮肤科学会指南：2025年基底细胞癌指南的临床问题
Hoashi, Toshihiko; Ishikawa, Masashi; Uehara, Jiro; Kamitani, Nobuhiko; Maeda, Shintaro; Nakamura, Yoshio; Shichinohe, Ryuji; Hirabayashi, Megumi; Miyagaki, Tomomitsu; Koga, Hiroshi; Nakamura, Yasuhiro; Uchi, Hiroshi 分享 收藏 分享 收藏 分享 收藏 Genomic and transcriptomic analysis of Japanese melanoma reveals candidate biomarkers for immune checkpoint inhibitor responders日本黑色素瘤的基因组学和转录组学分析揭示了免疫检查点抑制剂应答者的候选生物标志物Kimura, T.; Tanaka, N.; Maekawa, T.; Kiniwa, Y.; Okuyama, R.; Asai, J.; Matsushita, S.; Uchi, H.; Kato, H.; Nagase, K.; Kobayashi, A.; Tanemura, A.; Fujimura, T.; Yano, H.; Noda, T.; Kiyotani, K.; Mori, S.; Fukushima, S. 分享 收藏 Evaluation of nivolumab in cutaneous angiosarcoma management: The ANGIOCHECK study评估纳武利尤单抗在皮肤血管肉瘤管理中的应用：ANGIOCHECK研究Fujisawa, Y.; Namikawa, K.; Ishitsuki, S.; Yoshino, K.; Isei, T.; Kato, H.; Yanagi, T.; Yamamoto, Y.; Uchi, H.; Otsuka, A. 分享 收藏 Postoperative adjuvant therapy for 120 patients with melanoma, including acral and mucosal subtypes: a multicentre, observational study of 2-year follow-up resultsMuto, Yusuke; Kambayashi, Yumi; Kato, Hiroshi; Fukushima, Satoshi; Ito, Takamichi; Maekawa, Takeo; Shoichiro, Ishizuki; Uchi, Hiroshi; Matsushita, Shigeto; Yamamoto, Yuki; Yoshino, Koji; Fujisawa, Yasuhiro; Amagai, Ryo; Ohuchi, Kentaro; Hashimoto, Akira; Asano, Yoshihide; Fujimura, Taku 分享 收藏 Combined use of nivolumab and ipilimumab in Japanese patients with melanoma: a multicentre retrospective study of 111 casesFujisawa, Yasuhiro; Namikawa, Kenjiro; Yoshino, Koji; Kiniwa, Yukiko; Ito, Takamichi; Kato, Hiroshi; Matsushita, Shigeto; Hoashi, Toshihiko; Nakamura, Yasuhiro; Yoshikawa, Shusuke; Miyagawa, Takuya; Asai, Jun; Matsuya, Taisuke; Fukushima, Satoshi; Kato, Jyunji; Takenouchi, Tatsuya; Uchi, Hiroshi; Masuzawa, Mamiko; Yanagi, Teruki; Maekawa, Takeo 分享 收藏 Prognoses of patients with melanoma who continue/discontinue anti-programmed death-1 therapy after achieving a complete response in a real-world setting: a multicentre retrospective studyKato, Junji; Namikawa, Kenjiro; Uehara, Jiro; Nomura, Motoo; Nakamura, Yasuhiro; Uhara, Hisashi; Uchi, Hiroshi; Yoshikawa, Shusuke; Kiniwa, Yukiko; Nakamura, Yoshiyuki; Miyagawa, Takuya; Matsushita, Shigeto; Takenouchi, Tatsuya; Hatta, Naohito; Ohno, Fumitaka; Maeda, Taku; Fukushima, Satoshi; Yamazaki, Naoya 分享 收藏 Adjuvant Anti-PD-1 Antibody Therapy for Advanced Melanoma: A Multicentre Study of 78 Japanese CasesMuto, Yusuke; Kambayashi, Yumi; Kato, Hiroshi; Fukushima, Satoshi; Ito, Takamichi; Maekawa, Takeo; Fujisawa, Yasuhiro; Yoshino, Koji; Uchi, Hiroshi; Matsushita, Shigeto; Yamamoto, Yuki; Amagai, Ryo; Ohuchi, Kentaro; Hashimoto, Akira; Fujimura, Taku 分享 收藏 Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 casesFujisawa, Yasuhiro; Ito, Takamichi; Kato, Hiroshi; Irie, Hiroyuki; Kaji, Tatsuya; Maekawa, Takeo; Asai, Jun; Yamamoto, Yuki; Fujimura, Taku; Nakai, Yasuo; Yasuda, Masahito; Matsuyama, Kanako; Muto, Ikko; Matsushita, Shigeto; Uchi, Hiroshi; Nakamura, Yoshiyuki; Uehara, Jiro; Yoshino, Koji 分享 收藏 Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patientsAnti-PD1检查点抑制剂治疗肢端黑色素瘤: 一项针对193名日本患者的多中心研究Nakamura, Y.; Namikawa, K.; Yoshino, K.; Yoshikawa, S.; Uchi, H.; Goto, K.; Fukushima, S.; Kiniwa, Y.; Takenouchi, T.; Uhara, H.; Kawai, T.; Hatta, N.; Funakoshi, T.; Teramoto, Y.; Otsuka, A.; Doi, H.; Ogata, D.; Matsushita, S.; Isei, T.; Hayashi, T.; Shibayama, Y.; Yamazaki, N. 分享 收藏 The efficacy of eribulin mesylate for patients with cutaneous angiosarcoma previously treated with taxane: a multicentre prospective observational studyFujisawa, Y.; Fujimura, T.; Matsushita, S.; Yamamoto, Y.; Uchi, H.; Otsuka, A.; Funakoshi, T.; Miyagi, T.; Hata, H.; Gosho, M.; Kambayashi, Y.; Aoki, M.; Yanagi, T.; Ohira, A.; Nakamura, Y.; Maeda, T.; Yoshino, K. 分享 收藏 分享 收藏 Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19Fujimura, T.; Tanita, K.; Sato, Y.; Lyu, C.; Kambayashi, Y.; Fujisawa, Y.; Uchi, H.; Yamamoto, Y.; Otsuka, A.; Yoshino, K.; Matsushita, S.; Funakoshi, T.; Fukushima, S.; Hata, H.; Hashimoto, A.; Aiba, S. 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
